Abstract: The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.
Type:
Grant
Filed:
May 23, 1997
Date of Patent:
October 12, 1999
Assignees:
Baxter International Inc., Miles G. Johnston
Inventors:
Chi J. Chen, Ty R. Shockley, Miles G. Johnston